109 related articles for article (PubMed ID: 19555696)
21. Structure of the tetrameric form of human L-Xylulose reductase: probing the inhibitor-binding site with molecular modeling and site-directed mutagenesis.
El-Kabbani O; Carbone V; Darmanin C; Ishikura S; Hara A
Proteins; 2005 Aug; 60(3):424-32. PubMed ID: 15906319
[TBL] [Abstract][Full Text] [Related]
22. S-nitrosoglutathione covalently modifies cysteine residues of human carbonyl reductase 1 and affects its activity.
Hartmanová T; Tambor V; Lenčo J; Staab-Weijnitz CA; Maser E; Wsól V
Chem Biol Interact; 2013 Feb; 202(1-3):136-45. PubMed ID: 23295225
[TBL] [Abstract][Full Text] [Related]
23. Coenzyme specificity of human monomeric carbonyl reductase: contribution of Lys-15, Ala-37 and Arg-38.
Sciotti M; Wermuth B
Chem Biol Interact; 2001 Jan; 130-132(1-3):871-8. PubMed ID: 11306102
[TBL] [Abstract][Full Text] [Related]
24. Molecular docking for substrate identification: the short-chain dehydrogenases/reductases.
Favia AD; Nobeli I; Glaser F; Thornton JM
J Mol Biol; 2008 Jan; 375(3):855-74. PubMed ID: 18036612
[TBL] [Abstract][Full Text] [Related]
25. New enzymes for old: redesigning the coenzyme and substrate specificities of glutathione reductase.
Perham RN; Scrutton NS; Berry A
Bioessays; 1991 Oct; 13(10):515-25. PubMed ID: 1755827
[TBL] [Abstract][Full Text] [Related]
26. Coenzyme binding in F420-dependent secondary alcohol dehydrogenase, a member of the bacterial luciferase family.
Aufhammer SW; Warkentin E; Berk H; Shima S; Thauer RK; Ermler U
Structure; 2004 Mar; 12(3):361-70. PubMed ID: 15016352
[TBL] [Abstract][Full Text] [Related]
27. X-ray crystallographic and enzymatic analyses of shikimate dehydrogenase from Staphylococcus epidermidis.
Han C; Hu T; Wu D; Qu S; Zhou J; Ding J; Shen X; Qu D; Jiang H
FEBS J; 2009 Feb; 276(4):1125-39. PubMed ID: 19215302
[TBL] [Abstract][Full Text] [Related]
28. Carbonyl Reductase 1 Plays a Significant Role in Converting Doxorubicin to Cardiotoxic Doxorubicinol in Mouse Liver, but the Majority of the Doxorubicinol-Forming Activity Remains Unidentified.
Breysse DH; Boone RM; Long CM; Merrill ME; Schaupp CM; White CC; Kavanagh TJ; Schmidt EE; Merrill GF
Drug Metab Dispos; 2020 Mar; 48(3):187-197. PubMed ID: 31955137
[TBL] [Abstract][Full Text] [Related]
29. A functional genetic polymorphism on human carbonyl reductase 1 (CBR1 V88I) impacts on catalytic activity and NADPH binding affinity.
Gonzalez-Covarrubias V; Ghosh D; Lakhman SS; Pendyala L; Blanco JG
Drug Metab Dispos; 2007 Jun; 35(6):973-80. PubMed ID: 17344335
[TBL] [Abstract][Full Text] [Related]
30. Carbonyl reduction of mequindox by chicken and porcine cytosol and cloned carbonyl reductase 1.
Tang X; Mu P; Wu J; Jiang J; Zhang C; Zheng M; Deng Y
Drug Metab Dispos; 2012 Apr; 40(4):788-95. PubMed ID: 22266778
[TBL] [Abstract][Full Text] [Related]
31. Cloning and bacterial expression of monomeric short-chain dehydrogenase/reductase (carbonyl reductase) from CHO-K1 cells.
Terada T; Sugihara Y; Nakamura K; Sato R; Inazu N; Maeda M
Eur J Biochem; 2000 Dec; 267(23):6849-57. PubMed ID: 11082196
[TBL] [Abstract][Full Text] [Related]
32. Mapping of a novel human carbonyl reductase, CBR3, and ribosomal pseudogenes to human chromosome 21q22.2.
Watanabe K; Sugawara C; Ono A; Fukuzumi Y; Itakura S; Yamazaki M; Tashiro H; Osoegawa K; Soeda E; Nomura T
Genomics; 1998 Aug; 52(1):95-100. PubMed ID: 9740676
[TBL] [Abstract][Full Text] [Related]
33. Carbonyl reductase sniffer from the model organism daphnia: Cloning, substrate determination and inhibitory sensitivity.
Strehse JS; Protopapas N; Maser E
Chem Biol Interact; 2019 Jul; 307():29-36. PubMed ID: 30991043
[TBL] [Abstract][Full Text] [Related]
34. Prediction of structurally conserved regions of D-specific hydroxy acid dehydrogenases by multiple alignment with formate dehydrogenase.
Vinals C; Depiereux E; Feytmans E
Biochem Biophys Res Commun; 1993 Apr; 192(1):182-8. PubMed ID: 8476420
[TBL] [Abstract][Full Text] [Related]
35. A model of structure and catalysis for ketoreductase domains in modular polyketide synthases.
Reid R; Piagentini M; Rodriguez E; Ashley G; Viswanathan N; Carney J; Santi DV; Hutchinson CR; McDaniel R
Biochemistry; 2003 Jan; 42(1):72-9. PubMed ID: 12515540
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of 8-hydroxy-2-iminochromene derivatives as selective and potent inhibitors of human carbonyl reductase 1.
Hu D; Miyagi N; Arai Y; Oguri H; Miura T; Nishinaka T; Terada T; Gouda H; El-Kabbani O; Xia S; Toyooka N; Hara A; Matsunaga T; Ikari A; Endo S
Org Biomol Chem; 2015 Jul; 13(27):7487-99. PubMed ID: 26068795
[TBL] [Abstract][Full Text] [Related]
37. Molecular basis for peroxisomal localization of tetrameric carbonyl reductase.
Tanaka N; Aoki K; Ishikura S; Nagano M; Imamura Y; Hara A; Nakamura KT
Structure; 2008 Mar; 16(3):388-97. PubMed ID: 18334214
[TBL] [Abstract][Full Text] [Related]
38. Highly active mutants of carbonyl reductase S1 with inverted coenzyme specificity and production of optically active alcohols.
Morikawa S; Nakai T; Yasohara Y; Nanba H; Kizaki N; Hasegawa J
Biosci Biotechnol Biochem; 2005 Mar; 69(3):544-52. PubMed ID: 15784983
[TBL] [Abstract][Full Text] [Related]
39. Human carbonyl reductases.
Malátková P; Maser E; Wsól V
Curr Drug Metab; 2010 Oct; 11(8):639-58. PubMed ID: 20942781
[TBL] [Abstract][Full Text] [Related]
40. Metabolism of doxorubicin to the cardiotoxic metabolite doxorubicinol is increased in a mouse model of chronic glutathione deficiency: A potential role for carbonyl reductase 3.
Schaupp CM; White CC; Merrill GF; Kavanagh TJ
Chem Biol Interact; 2015 Jun; 234():154-61. PubMed ID: 25446851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
